Importance of prosthetic valve hemodynamics in the low risk AS population following TAVR or SAVR-1
1- Describe the role and evolution of TAVI in the low risk population and in the patients with a small annulus.
2- Raise the importance of valve hemodynamics following TAVI or SAVR in the low risk population.
3- Use appropriate methods to measure transvalvular pressure gradients and effective orifice area (EOA) by echo.
4- Apply the methods and criteria to identify and quantify prosthesis-patient mismatch, structural and non-structural bioprosthetic valve dysfunction.
David Messika-Zeitoun, UOHI, Ottawa, Geraldine Ong, Toronto
1- TAVI vs. SAVR in AS: Specifics for Low Risk and Small Annulus. Josep Rodés-Cabau. Québec. 20 min
2- How to measure valve hemodynamics (gradients, EOA) by echo post SAVR and TAVI.
Heather Cooley, Foothills Hospital, Calgary, 20 min
3- Definition, predictors, and impact of prosthesis-patient mismatch and bioprosthetic valve dysfunction following TAVI vs. SAVR. Philippe Pibarot. Québec Heart & Lung Institute, Québec. 20 min
The Canadian Society of Echocardiography (CSE) is a non-profit organization of cardiovascular professionals committed to excellence in Echocardiography.